Symposium Highlights Techniques to Manage Heart Infections


Monday, January 29
1:30 p.m. – 3:30 p.m.
Room 304

Juan P. Umaña, MD

Infectious heart disease, especially as a result of the current opioid epidemic, is on the rise among young adults. At the International Symposium, surgeons from around the world will explain their approaches to dealing with these infections, the central challenges they face, and the ethical disease management dilemmas related to infectious heart disease in young adults.

“Many surgeons in developing countries don’t have the resources they need to treat these patients,” said session moderator Juan P. Umaña, MD, of Fundacion Cardoinfantil-Institute of Cardiology in Bogota, Colombia. “Imaging techniques are not readily available, so discussing a simple algorithm in how to approach these patients will be a major focus.”

Taweesak Chotivatanapong, MD will explain approaches he uses in the treatment of infected mitral valves in patients with rheumatic heart disease. Dr. Chotivatanapong is from the Central Chest Institute of Thailand.

The symposium’s focus will then shift to the bicuspid aortic valve in a presentation by Joseph E. Bavaria, MD, of the University of Pennsylvania in Philadelphia.

“One of the issues in developing countries is the fact that aortic and mitral valves  don’t get repaired as often as they should,”  Dr. Umaña said. “Dr. Bavaria will talk about how to repair and secure the infected bicuspid aortic valve. He will review the long-term prognosis of the repaired valve in young adults.”

Michele De Bonis, MD will examine the timing of surgery for endocarditis to avoid neurological complications. He is a surgeon at Vita-Salute San Raffaele University in Milan, Italy.

“With less access to medical and dental care, patients tend to have more infections of native valves or previously implanted prostheses,” Dr. Umaña said. “This will focus on two big issues—the fact that valves need to be repaired more often and how to approach and repair those infected valves.”

Enrico Ferrari, MD, of Cardiocentro Ticino in Lugano, Switzerland, will explain transcatheter interventions for previous repairs that are failing.

“This talk will bring into the mix technologies that are being applied in developed countries and try to rationalize  their use for the international community,”  Dr. Umaña said.

Darshan Reddy, MBChB will discuss the use of anticoagulants and how they can affect valve thrombosis. He is from Inkosi Albert Luthuli Central Hospital in Durban, South Africa.

“Thrombosis of a previously implanted prosthesis is a big issue,” Dr. Umaña said. “How to handle them pharmacologically or perhaps mechanically is something that is worth discussing.”

To wrap up the session, Joseph S. Coselli, MD, of the Texas Heart Institute in Houston, will explain the latest treatments used at his institution to manage infected aortic prostheses, particularly Dacron tubes or endoprostheses.

“This is a big issue because often you are faced with young patients who require extensive operations to remove the bulk of the disease,” Dr. Umaña said. “That may require extra-anatomic bypasses or the use of homografts that sometimes are not available in developing countries. This talk will be of tremendous value to the international community.”